Protective roles of CX3CR1-mediated signals in toxin A-induced enteritis through the induction of heme oxygenase-1 expression

Journal of Immunology

Volumn 186, Issue 1, 2011, Pages 423-431

  Inui, Masanori ^a   Ishida, Yuko ^a   Kimura, Akihiko ^a   Kuninaka, Yumi ^a   Mukaida, Naofumi ^b   Kondo, Toshikazu ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CHEMOKINE RECEPTOR CX3CR1; CLOSTRIDIUM DIFFICILE TOXIN A; FRACTALKINE; HEME OXYGENASE 1; HEME OXYGENASE 1 INHIBITOR; HEME OXYGENASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTOPORPHYRIN TIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL INFILTRATION; CELL ISOLATION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE EXACERBATION; ENTERITIS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENE INDUCTION; HEMATOPOIETIC CELL; HISTOPATHOLOGY; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; LAMINA PROPRIA; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIAL TOXINS; CELL LINE; CHEMOKINE CX3CL1; CLOSTRIDIUM DIFFICILE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENTERITIS; ENTEROTOXINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; MACROPHAGES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCOUS MEMBRANE; RECEPTORS, CHEMOKINE; UP-REGULATION;

EID: 79251569234     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000043     Document Type: Article

References (61)

1. Mylonakis, E., E. T. Ryan, and S. B. Calderwood. 2001. Clostridium difficile - Associated diarrhea: A review. Arch. Intern. Med. 161: 525-533.
2. Kelly, C. P., and J. T. LaMont. 1998. Clostridium difficile infection. Annu. Rev. Med. 49: 375-390.
3. Bignardi, G. E. 1998. Risk factors for Clostridium difficile infection. J. Hosp. Infect. 40: 1-15.
4. Anand, A., and A. E. Glatt. 1993. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin. Infect. Dis. 17: 109-113.
5. Blot, E., M. C. Escande, D. Besson, F. Barbut, C. Granpeix, B. Asselain, M. C. Falcou, and P. Pouillart. 2003. Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. J. Hosp. Infect. 53: 187-192.
6. Sharma, A. K., and F. E. Holder. 1998. Clostridium difficile diarrhea after use of tacrolimus following renal transplantation. Clin. Infect. Dis. 27: 1540-1541.
7. Voth, D. E., and J. D. Ballard. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18: 247-263.
8. Ishida, Y., T. Maegawa, T. Kondo, A. Kimura, Y. Iwakura, S. Nakamura, and N. Mukaida. 2004. Essential involvement of IFN-γ in Clostridium difficile toxin A-induced enteritis. J. Immunol. 172: 3018-3025. (Pubitemid 38263690)
9. Rocha, M. F., M. E. Maia, L. R. Bezerra, D. M. Lyerly, R. L. Guerrant, R. A. Ribeiro, and A. A. Lima. 1997. Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes. Infect. Immun. 65: 2740-2746.
10. Morteau, O., I. Castagliuolo, A. Mykoniatis, J. Zacks, M. Wlk, B. Lu, C. Pothoulakis, N. P. Gerard, and C. Gerard. 2002. Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice. Gastroenterology 122: 725-733.
11. Castagliuolo, I., A. C. Keates, C. C. Wang, A. Pasha, L. Valenick, C. P. Kelly, S. T. Nikulasson, J. T. LaMont, and C. Pothoulakis. 1998. Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells. J. Immunol. 160: 6039-6045.
12. Castagliuolo, I., M. Riegler, A. Pasha, S. Nikulasson, B. Lu, C. Gerard, N. P. Gerard, and C. Pothoulakis. 1998. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis. J. Clin. Invest. 101: 1547-1550.
13. Kim, J. M., J. S. Kim, H. C. Jun, Y. K. Oh, I. S. Song, and C. Y. Kim. 2002. Differential expression and polarized secretion of CXC and CC chemokines by human intestinal epithelial cancer cell lines in response to Clostridium difficile toxin A. Microbiol. Immunol. 46: 333-342.
14. Alcantara, C., W. F. Stenson, T. S. Steiner, and R. L. Guerrant. 2001. Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A-induced secretion and inflammation in an animal model. J. Infect. Dis. 184: 648-652.
15. Pothoulakis, C., and J. T. Lamont. 2001. Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G178-G183.
16. Fong, A. M., L. A. Robinson, D. A. Steeber, T. F. Tedder, O. Yoshie, T. Imai, and D. D. Patel. 1998. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188: 1413-1419.
17. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640-644.
18. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T. J. Schall, and O. Yoshie. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521-530.
19. Brand, S., K. Hofbauer, J. Dambacher, F. Schnitzler, T. Staudinger, S. Pfennig, J. Seiderer, C. Tillack, A. Konrad, B. Göke, et al. 2006. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype. Am. J. Gastroenterol. 101: 99-106.
20. Murphy, G., N. Caplice, and M. Molloy. 2008. Fractalkine in rheumatoid arthritis: a review to date. Rheumatology (Oxford) 47: 1446-1451.
21. Ishida, Y., T. Hayashi, T. Goto, A. Kimura, S. Akimoto, N. Mukaida, and T. Kondo. 2008. Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis. J. Immunol. 181: 4208-4218.
22. Lu, P., L. Li, K. Kuno, Y. Wu, T. Baba, Y. Y. Li, X. Zhang, and N. Mukaida. 2008. Protective roles of the fractalkine/CX3CL1-CX3CR1 interactions in alkali-induced corneal neovascularization through enhanced antiangiogenic factor expression. J. Immunol. 180: 4283-4291.
23. Furuichi, K., J. L. Gao, and P. M. Murphy. 2006. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am. J. Pathol. 169: 372-387.
24. Combadière, C., S. Potteaux, J. L. Gao, B. Esposito, S. Casanova, E. J. Lee, P. Debré, A. Tedgui, P. M. Murphy, and Z. Mallat. 2003. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107: 1009-1016. (Pubitemid 36258725)
25. -/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111: 333-340.
26. Teupser, D., S. Pavlides, M. Tan, J. C. Gutierrez-Ramos, R. Kolbeck, and J. L. Breslow. 2004. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc. Natl. Acad. Sci. USA 101: 17795-17800.
27. Kostadinova, F. I., T. Baba, Y. Ishida, T. Kondo, B. K. Popivanova, and N. Mukaida. 2010. Crucial involvement of the CX3CR1-CX3CL1 axis in dextran sulfate sodium-mediated acute colitis in mice. J. Leukoc. Biol. 88: 133-143.
28. Ishida, Y., A. Kimura, T. Kondo, T. Hayashi, M. Ueno, N. Takakura, K. Matsushima, and N. Mukaida. 2007. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am. J. Pathol. 170: 843-854.
29. Ishida, Y., T. Kondo, A. Kimura, K. Tsuneyama, T. Takayasu, and N. Mukaida. 2006. Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury. Eur. J. Immunol. 36: 1028-1038.
30. Denning, T. L., Y. C. Wang, S. R. Patel, I. R. Williams, and B. Pulendran. 2007. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8: 1086-1094.
31. Mizutani, N., T. Sakurai, T. Shibata, K. Uchida, J. Fujita, R. Kawashima, Y. I. Kawamura, N. Toyama-Sorimachi, T. Imai, and T. Dohi. 2007. Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. J. Immunol. 179: 7478-7487.
32. Willis, D., A. R. Moore, R. Frederick, and D. A. Willoughby. 1996. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2: 87-90.
33. Deshane, J., M. Wright, and A. Agarwal. 2005. Heme oxygenase-1 expression in disease states. Acta Biochim. Pol. 52: 273-284.
34. Zhang, X., E. L. Bedard, R. Potter, R. Zhong, J. Alam, A. M. Choi, and P. J. Lee. 2002. Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemiareperfusion lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L815-L829.
35. Qiu, B., C. Pothoulakis, I. Castagliuolo, S. Nikulasson, and J. T. LaMont. 1999. Participation of reactive oxygen metabolites in Clostridium difficile toxin Ainduced enteritis in rats. Am. J. Physiol. 276: G485-G490.
36. Jefferson, K. K., M. F. Smith, Jr., and D. A. Bobak. 1999. Roles of intracellular calcium and NF-k B in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes. J. Immunol. 163: 5183-5191.
37. Linevsky, J. K., C. Pothoulakis, S. Keates, M. Warny, A. C. Keates, J. T. Lamont, and C. P. Kelly. 1997. IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes. Am. J. Physiol. 273: G1333-G1340.
38. Warny, M., A. C. Keates, S. Keates, I. Castagliuolo, J. K. Zacks, S. Aboudola, A. Qamar, C. Pothoulakis, J. T. LaMont, and C. P. Kelly. 2000. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J. Clin. Invest. 105: 1147-1156.
39. Yang, X. P., S. Mattagajasingh, S. Su, G. Chen, Z. Cai, K. Fox-Talbot, K. Irani, and L. C. Becker. 2007. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells throughCX3CR1 and the Jak Stat5 pathway. Circ. Res. 101: 1001-1008.
40. Feng, L., S. Chen, G. E. Garcia, Y. Xia, M. A. Siani, P. Botti, C. B. Wilson, J. K. Harrison, and K. B. Bacon. 1999. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int. 56: 612-620.
41. Ishida, Y., J. L. Gao, and P. M. Murphy. 2008. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J. Immunol. 180: 569-579.
42. Cook, D. N., S. C. Chen, L. M. Sullivan, D. J. Manfra, M. T. Wiekowski, D. M. Prosser, G. Vassileva, and S. A. Lira. 2001. Generation and analysis of mice lacking the chemokine fractalkine. Mol. Cell. Biol. 21: 3159-3165.
43. Jung, S., J. Aliberti, P. Graemmel, M. J. Sunshine, G. W. Kreutzberg, A. Sher, and D. R. Littman. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20: 4106-4114.
44. Gomes, R. N., R. T. Figueiredo, F. A. Bozza, P. Pacheco, R. T. Amâncio, A. P. Laranjeira, H. C. Castro-Faria-Neto, P. T. Bozza, and M. T. Bozza. 2006. Increased susceptibility to septic and endotoxic shock in monocyte chemoattractant protein 1/cc chemokine ligand 2-deficient mice correlates with reduced interleukin 10 and enhanced macrophage migration inhibitory factor production. Shock 26: 457-463.
45. Matsukawa, A., C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, R. M. Strieter, and S. L. Kunkel. 1999. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J. Immunol. 163: 6148-6154.
46. Kurihara, T., G. Warr, J. Loy, and R. Bravo. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186: 1757-1762.
47. Boring, L., J. Gosling, S. W. Chensue, S. L. Kunkel, R. V. Farese, Jr., H. E. Broxmeyer, and I. F. Charo. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100: 2552-2561.
48. Kuziel, W. A., S. J. Morgan, T. C. Dawson, S. Griffin, O. Smithies, K. Ley, and N. Maeda. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 94: 12053-12058.
49. + monocytes is essential for control of acute toxoplasmosis. J. Exp. Med. 201: 1761-1769.
50. Yoshinaga, T., S. Sassa, and A. Kappas. 1982. The oxidative degradation of heme c by the microsomal heme oxygenase system. J. Biol. Chem. 257: 7803-7807.
51. Yoshida, T., and G. Kikuchi. 1979. Purification and properties of heme oxygenase from rat liver microsomes. J. Biol. Chem. 254: 4487-4491.
52. Yoneya, R., H. Ozasa, Y. Nagashima, Y. Koike, H. Teraoka, K. Hagiwara, and S. Horikawa. 2000. Hemin pretreatment ameliorates aspects of the nephropathy induced by mercuric chloride in the rat. Toxicol. Lett. 116: 223-229.
53. Odaka, Y., T. Takahashi, A. Yamasaki, T. Suzuki, T. Fujiwara, T. Yamada, M. Hirakawa, H. Fujita, E. Ohmori, and R. Akagi. 2000. Prevention of halothane-induced hepatotoxicity by hemin pretreatment: protective role of heme oxygenase-1 induction. Biochem. Pharmacol. 59: 871-880.
54. Wang, W. P., X. Guo, M. W. Koo, B. C. Wong, S. K. Lam, Y. N. Ye, and C. H. Cho. 2001. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G586-G594.
55. Chora, A. A., P. Fontoura, A. Cunha, T. F. Pais, S. Cardoso, P. P. Ho, L. Y. Lee, R. A. Sobel, L. Steinman, and M. P. Soares. 2007. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 117: 438-447.
56. Hegazi, R. A., K. N. Rao, A. Mayle, A. R. Sepulveda, L. E. Otterbein, and S. E. Plevy. 2005. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J. Exp. Med. 202: 1703-1713.
57. Kobayashi, T., K. Hirano, T. Yamamoto, G. Hasegawa, K. Hatakeyama, M. Suematsu, and M. Naito. 2002. The protective role of Kupffer cells in the ischemia-reperfused rat liver. Arch. Histol. Cytol. 65: 251-261.
58. Meucci, O., A. Fatatis, A. A. Simen, T. J. Bushell, P. W. Gray, and R. J. Miller. 1998. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95: 14500-14505.
59. Maciejewski-Lenoir, D., S. Chen, L. Feng, R. Maki, and K. B. Bacon. 1999. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J. Immunol. 163: 1628-1635.
60. Brand, S., T. Sakaguchi, X. Gu, S. P. Colgan, and H. C. Reinecker. 2002. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 122: 166-177.
61. Chandrasekar, B., S. Mummidi, R. P. Perla, S. Bysani, N. O. Dulin, F. Liu, and P. C. Melby. 2003. Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem. J. 373: 547-558.